Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Ordinary Shares, par value US$0.0001 per share
-
Shares outstanding
-
20,679,958
-
Total 13F shares
-
929,752
-
Share change
-
+929,652
-
Total reported value
-
$2,152,582
-
Price per share
-
$2.32
-
Number of holders
-
19
-
Value change
-
+$2,152,350
-
Number of buys
-
18
Institutional Holders of CASI Pharmaceuticals, Inc. - Ordinary Shares, par value US$0.0001 per share (CASI) as of Q1 2023
As of 31 Mar 2023,
CASI Pharmaceuticals, Inc. - Ordinary Shares, par value US$0.0001 per share (CASI) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
929,752 shares.
The largest 10 holders included
VANGUARD GROUP INC, Wellington Shields Capital Management, LLC, Wellington Shields & Co., LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., SUSQUEHANNA INTERNATIONAL GROUP, LLP, STATE STREET CORP, NORTHERN TRUST CORP, FRANKLIN RESOURCES INC, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
19
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.